journal article·2023-07Open access

Engineered Extracellular Vesicles Derived from Dermal Fibroblasts Attenuate Inflammation in a Murine Model of Acute Lung Injury

Ana I. Salazar‐Puerta, María A. Rincon‐Benavides, Tatiana Z. Cuellar‐Gaviria, Julian Aldana, Gabriela Vasquez Martinez, Lilibeth Ortega‐Pineda, Devleena Das, Daniel Dodd, Charles A. Spencer, Binbin Deng, David W. McComb, Joshua A. Englert, Samir Ghadiali, Diana Zepeda‐Orozco, Loren E. Wold, Daniel Gallego‐Perez, Natalia Higuita‐Castro

Advanced Materials· Volume 35· Issue 28

Abstract

Abstract Acute respiratory distress syndrome (ARDS) represents a significant burden to the healthcare system, with ≈200 000 cases diagnosed annually in the USA. ARDS patients suffer from severe refractory hypoxemia, alveolar‐capillary barrier dysfunction, impaired surfactant function, and abnormal upregulation of inflammatory pathways that lead to intensive care unit admission, prolonged hospitalization, and increased disability‐adjusted life years. Currently, there is no cure or FDA‐approved therapy for ARDS. This work describes the implementation of engineered extracellular vesicle (eEV)‐based nanocarriers for targeted nonviral delivery of anti‐inflammatory payloads to the inflamed/injured lung. The results show the ability of surfactant protein A (SPA)‐functionalized IL‐4‐ and IL‐10‐loaded eEVs to promote intrapulmonary retention and reduce inflammation, both in vitro and in vivo. Significant attenuation is observed in tissue damage, proinflammatory cytokine secretion, macrophage activation, influx of protein‐rich fluid, and neutrophil infiltration into the alveolar space as early as 6 h post‐eEVs treatment. Additionally, metabolomics analyses show that eEV treatment causes significant changes in the metabolic profile of inflamed lungs, driving the secretion of key anti‐inflammatory metabolites. Altogether, these results establish the potential of eEVs derived from dermal fibroblasts to reduce inflammation, tissue damage, and the prevalence/progression of injury during ARDS via nonviral delivery of anti‐inflammatory genes/transcripts.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Extracellular vesicles in disease · Thermal Regulation in Medicine · Air Quality and Health Impacts

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Biomedical Engineering The Ohio State University Columbus OH 43210 USA

Biophysics Program The Ohio State University Columbus OH 43210 USA

Biochemistry Program The Ohio State University Columbus OH 43210 USA

Kidney and Urinary Tract Research Center The Abigail Wexner Research Institute Nationwide Children's Hospital Columbus OH 43215 USA

Biomedical Science Graduate Program The Ohio State University Columbus OH 43210 USA

Division of Cardiac Surgery Department of Surgery The Ohio State University Columbus OH 43210 USA

Center for Electron Microscopy and Analysis (CEMAS) The Ohio State University Columbus OH 43212 USA

Department of Materials Science and Engineering The Ohio State University Columbus OH 43210 USA

Division of Pulmonary, Critical Care, and Sleep Medicine The Ohio State University Columbus OH 43221 USA

Department of Pediatrics The Ohio State University Columbus OH 43210 USA

Division of Pediatric Nephrology and Hypertension Nationwide Children's Hospital Columbus OH 43205 USA

Division of General Surgery Department of Surgery The Ohio State University Columbus OH 43210 USA

Dorothy M. Davis Heart & Lung Research Institute The Ohio State University Columbus OH 43210 USA

Gene Therapy Institute The Ohio State University Columbus OH 43210 USA

Funding

National Institutes of Health

References (100+)

Show source-provided references
1. Moss M. · 2010 · 1
2. 10.1378/chest.06-197610.1378/chest.06-1976 ↗
3. 10.1089/jamp.2009.077510.1089/jamp.2009.0775 ↗
4. 10.4187/respcare.0471610.4187/respcare.04716 ↗
5. 10.1177/088506661985502110.1177/0885066619855021 ↗
6. 10.1055/s-0039-168399610.1055/s-0039-1683996 ↗
7. 10.1146/annurev-pathol-011110-13015810.1146/annurev-pathol-011110-130158 ↗
8. 10.4049/jimmunol.140251310.4049/jimmunol.1402513 ↗
9. 10.4103/0974-2700.5866310.4103/0974-2700.58663 ↗
10. Bhatia M. · J. Pathol. Clin. Res. · 2004 · 202 · 145
11. 10.1002/jcp.2531610.1002/jcp.25316 ↗
12. 10.1096/fj.11-19924010.1096/fj.11-199240 ↗
13. 10.1172/JCI6033110.1172/JCI60331 ↗
14. 10.1056/NEJMra160807710.1056/NEJMra1608077 ↗
15. 10.1080/14712598.2016.121884510.1080/14712598.2016.1218845 ↗
16. 10.1038/s41598-021-82492-x10.1038/s41598-021-82492-x ↗
17. 10.5694/mja2.5067410.5694/mja2.50674 ↗
18. 10.1371/journal.ppat.100853610.1371/journal.ppat.1008536 ↗
19. 10.1007/s10140-021-01976-510.1007/s10140-021-01976-5 ↗
20. 10.1155/2019/543213410.1155/2019/5432134 ↗
21. 10.21037/atm.2017.08.2810.21037/atm.2017.08.28 ↗
22. 10.1016/j.lfs.2020.11776610.1016/j.lfs.2020.117766 ↗
23. 10.1097/MCC.000000000000006110.1097/MCC.0000000000000061 ↗
24. 10.3389/fneur.2019.0065610.3389/fneur.2019.00656 ↗
25. 10.1038/nm.326710.1038/nm.3267 ↗
26. 10.1002/jcp.2531610.1002/jcp.25316 ↗
27. 10.3390/ijms1701007810.3390/ijms17010078 ↗
28. 10.1208/s12248-009-9143-y10.1208/s12248-009-9143-y ↗
29. 10.1002/jex2.6010.1002/jex2.60 ↗
30. 10.1089/ten.teb.2014.030010.1089/ten.teb.2014.0300 ↗
31. 10.1034/j.1600-0854.2002.30502.x10.1034/j.1600-0854.2002.30502.x ↗
32. 10.1126/science.aau697710.1126/science.aau6977 ↗
33. 10.3390/cells1005096510.3390/cells10050965 ↗
34. 10.1038/s41580-020-0251-y10.1038/s41580-020-0251-y ↗
35. 10.1016/j.apsb.2016.02.00110.1016/j.apsb.2016.02.001 ↗
36. 10.1126/science.aau697710.1126/science.aau6977 ↗
37. 10.1080/20013078.2020.179536510.1080/20013078.2020.1795365 ↗
38. 10.1152/ajplung.00546.201810.1152/ajplung.00546.2018 ↗
39. 10.3390/ijms2107231810.3390/ijms21072318 ↗
40. 10.1038/s41577-022-00763-810.1038/s41577-022-00763-8 ↗
41. 10.3389/fbioe.2020.59846610.3389/fbioe.2020.598466 ↗
42. 10.1038/s41578-020-00277-610.1038/s41578-020-00277-6 ↗
43. 10.1002/adhm.20210080510.1002/adhm.202100805 ↗
44. 10.1002/adhm.20210161910.1002/adhm.202101619 ↗
45. 10.1007/978-1-4939-9740-4_810.1007/978-1-4939-9740-4_8 ↗
46. 10.22203/eCM.v041a0710.22203/eCM.v041a07 ↗
47. 10.1126/sciadv.abd473510.1126/sciadv.abd4735 ↗
48. 10.1038/nnano.2017.13410.1038/nnano.2017.134 ↗
49. 10.1002/adtp.20220019710.1002/adtp.202200197 ↗
50. 10.1021/bi200167d10.1021/bi200167d ↗
51. 10.1152/ajpcell.00195.202010.1152/ajpcell.00195.2020 ↗
52. 10.1016/j.biocel.2016.11.00310.1016/j.biocel.2016.11.003 ↗
53. 10.1002/jbm.a.3186310.1002/jbm.a.31863 ↗
54. 10.3389/fimmu.2014.0053810.3389/fimmu.2014.00538 ↗
55. 10.1177/088532821881793910.1177/0885328218817939 ↗
56. 10.1152/ajplung.90233.200810.1152/ajplung.90233.2008 ↗
57. 10.1371/journal.pone.006399010.1371/journal.pone.0063990 ↗
58. 10.1016/j.biopha.2019.10874810.1016/j.biopha.2019.108748 ↗
59. 10.1186/s12931-020-01423-y10.1186/s12931-020-01423-y ↗
60. 10.1097/TA.000000000000174410.1097/TA.0000000000001744 ↗
61. 10.1038/s12276-019-0223-510.1038/s12276-019-0223-5 ↗
62. 10.1111/j.1742-481X.2012.01064.x10.1111/j.1742-481X.2012.01064.x ↗
63. 10.3390/ijms1505840710.3390/ijms15058407 ↗
64. 10.1038/s41536-021-00144-010.1038/s41536-021-00144-0 ↗
65. 10.1007/978-981-19-9805-8_410.1007/978-981-19-9805-8_4 ↗
66. Lai P. · Nonai Roka Seigyo to Baiomaka: Kiban Kenkyu to Shokuhin Sozai · 2019 · 7 · 6
67. 10.3390/ijms2211548710.3390/ijms22115487 ↗
68. 10.1172/JCI8113110.1172/JCI81131 ↗
69. 10.3390/ph1408082910.3390/ph14080829 ↗
70. 10.1038/s41598-018-27190-x10.1038/s41598-018-27190-x ↗
71. 10.1016/j.coph.2009.03.00210.1016/j.coph.2009.03.002 ↗
72. 10.1074/jbc.270.16.955810.1074/jbc.270.16.9558 ↗
73. 10.1006/jsre.1998.541810.1006/jsre.1998.5418 ↗
74. 10.4049/jimmunol.170.4.208310.4049/jimmunol.170.4.2083 ↗
75. 10.4049/jimmunol.162.9.522410.4049/jimmunol.162.9.5224 ↗
76. 10.1073/pnas.86.10.380310.1073/pnas.86.10.3803 ↗
77. 10.3402/jev.v3.2691310.3402/jev.v3.26913 ↗
78. 10.1016/j.phrs.2016.07.00610.1016/j.phrs.2016.07.006 ↗
79. 10.3390/pharmaceutics1211102210.3390/pharmaceutics12111022 ↗
80. 10.1016/j.ymeth.2019.10.00510.1016/j.ymeth.2019.10.005 ↗
81. 10.7150/thno.3085310.7150/thno.30853 ↗
82. 10.3390/pharmaceutics1211100610.3390/pharmaceutics12111006 ↗
83. 10.1016/0041-008X(88)90051-810.1016/0041-008X(88)90051-8 ↗
84. 10.1152/physiol.00017.201010.1152/physiol.00017.2010 ↗
85. 10.1111/j.1600-6143.2004.00352.x10.1111/j.1600-6143.2004.00352.x ↗
86. 10.1159/00027206210.1159/000272062 ↗
87. 10.3389/fphys.2020.0003610.3389/fphys.2020.00036 ↗
88. 10.4049/jimmunol.140118210.4049/jimmunol.1401182 ↗
89. 10.4049/jimmunol.174.8.503310.4049/jimmunol.174.8.5033 ↗
90. 10.1164/ajrccm.160.5.990109610.1164/ajrccm.160.5.9901096 ↗
91. 10.1152/jappl.1978.45.5.69910.1152/jappl.1978.45.5.699 ↗
92. 10.1097/01.CCM.0000149854.61192.DC10.1097/01.CCM.0000149854.61192.DC ↗
93. 10.1038/s41572-019-0069-010.1038/s41572-019-0069-0 ↗
94. 10.1152/ajplung.1999.276.1.L13710.1152/ajplung.1999.276.1.L137 ↗
95. 10.1164/ajrccm.155.6.919611210.1164/ajrccm.155.6.9196112 ↗
96. 10.1165/ajrcmb.24.5.415610.1165/ajrcmb.24.5.4156 ↗
97. 10.1165/rcmb.2021-0531ST10.1165/rcmb.2021-0531ST ↗
98. 10.1177/019262331559839910.1177/0192623315598399 ↗
99. 10.1097/CCE.000000000000020310.1097/CCE.0000000000000203 ↗
100. 10.1021/pr400762410.1021/pr4007624 ↗